Duloxetine Metabolism and Fibromyalgia

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions
FibromyalgiaDuloxetine
Interventions
DRUG

Observational

In a cohort of patients treated with duloxetine for fibromyalgia, participants vitals signs (blood pressure, heart rate, oxygen saturation level, temperature) will be taken as well as height and weight. Participants will fill out a questionnaire regarding their fibromyalgia diagnosis and symptoms. Lastly, participants will complete two sets of blood samples. One blood sample will evaluate genetic variants for duloxetine metabolizing capacity. The other sample will be used to analyze the level of concentration of duloxetine.

Trial Locations (1)

84132

RECRUITING

Pain Management Center and Pain Research Center at the University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER